Recent Finacing
Recent Raise
Avectas develops Solupore, a patented non‑viral ex‑vivo cell engineering delivery platform that transfects primary T and NK cells with mRNA, DNA, proteins and gene‑editing tools for cell therapy manufacturing.
Focus Areas
Total Raised
Funding rounds
See the team members at Avectas.
